SI-BONE SIBN 深 滬
等待開盤 10-28 09:30:00 美东时间
15.38
-0.110
-0.71%
華盛通- 最 高15.50
- 今 開15.50
- 成交量 12.78万股
- 最 低 15.165
- 昨 收 15.49
- 總市值 6.55亿
- 52周最高 20.05
- 市盈率 靜 --
- 換手率 0.30%
- 52周最低 11.70
- 委 比 -57.89%
- 總股本 4261.45万
- 歷史最高 37.21
- 量 比 0.79
- 振 幅 2.16%
- 歷史最低 7.20
- 每 手 1
- 風險率 1.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Real-World Evidence: SI-BONE’s Innovative Spinopelvic Study Update
Si-Bone (($SIBN)) announced an update on their ongoing clinical study. The stud...
56分钟前
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
Truist Securities Maintains Buy on SI-BONE, Lowers Price Target to $20
Truist Securities analyst David Rescott maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $22 to $20.
10-15 23:38
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025
SI-BONE, a medical device company specializing in sacropelvic disorders, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York. The company's management will host a fireside chat on September 9, 2025, at 4:00 a.m. PT / 7:00 a.m. ET. Investors can listen to the webcast via a provided link on the company’s website, which will be archived for 90 days. SI-BONE, a leader in minimally invasive SI joint f...
08-26 20:03
SI-BONE shares are trading lower. The company reported Q2 financial results.
SI-BONE shares are trading lower. The company reported Q2 financial results.
08-05 23:54
Cantor Fitzgerald Reiterates Overweight on SI-BONE, Maintains $25 Price Target
Cantor Fitzgerald analyst Ross Osborn reiterates SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.
08-05 20:23
SI-BONE Q2 EPS $(0.14) Beats $(0.19) Estimate, Sales $48.630M Beat $48.112M Estimate
SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 24.73 percent. This is a 36.36 percent increase over losses of $(0.22) per share from the same
08-05 04:09
Earnings Scheduled For August 4, 2025
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32
SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025
SI-BONE, a medical device company specializing in sacropelvic disorders, announced its participation in the Canaccord Genuity 45th Annual Growth Conference in Boston. Management will host a fireside chat on August 12, 2025, at 12:00 p.m. Pacific Time/03:00 p.m. Eastern Time. Investors can access the webcast via the provided link or visit the "Investors" section on SI-BONE's website. The webcast will be archived for 90 days. SI-BONE, a leader in m...
07-29 20:30
SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
SI-BONE, a medical device company focused on sacropelvic disorders, will report its second quarter 2025 financial results on August 4, 2025, after market close. Management will host a conference call at 4:30 p.m. ET, available for investors via registration. SI-BONE, a global leader in minimally invasive SI joint fusion, has supported over 125,000 procedures since launching its iFuse system in 2009, with over 175 peer-reviewed publications suppor...
07-14 20:09
